Wall Street Zen Downgrades Haleon (NYSE:HLN) to Hold

Haleon (NYSE:HLN) was downgraded by equities researchers at Wall Street Zen from a “buy” rating to a “hold” rating in a research report issued on Saturday.

Several other analysts have also recently commented on HLN. Argus upgraded shares of Haleon to a “strong-buy” rating in a report on Tuesday, March 17th. Rothschild & Co Redburn lowered shares of Haleon from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, June 16th. Weiss Ratings reiterated a “hold (c)” rating on shares of Haleon in a research report on Tuesday. Finally, Deutsche Bank Aktiengesellschaft reissued a “sell” rating on shares of Haleon in a research note on Thursday, April 30th. Two analysts have rated the stock with a Strong Buy rating, three have issued a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Haleon has an average rating of “Moderate Buy”.

Haleon Stock Down 0.2%

Shares of Haleon stock opened at $9.80 on Friday. Haleon has a 1 year low of $8.65 and a 1 year high of $11.28. The company has a market cap of $43.22 billion, a P/E ratio of 25.14, a P/E/G ratio of 2.29 and a beta of 0.13. The company has a current ratio of 0.92, a quick ratio of 0.71 and a debt-to-equity ratio of 0.47. The stock has a 50-day moving average price of $9.17 and a 200 day moving average price of $9.87.

Haleon (NYSE:HLN) last released its earnings results on Saturday, February 14th. The company reported $6.32 earnings per share for the quarter. The business had revenue of $3.65 billion for the quarter. As a group, analysts expect that Haleon will post 0.55 EPS for the current fiscal year.

Institutional Trading of Haleon

Several large investors have recently added to or reduced their stakes in the business. Parkside Financial Bank & Trust increased its stake in shares of Haleon by 101.3% during the 4th quarter. Parkside Financial Bank & Trust now owns 2,847 shares of the company’s stock worth $29,000 after purchasing an additional 1,433 shares during the last quarter. Western Wealth Management LLC acquired a new stake in shares of Haleon in the 1st quarter valued at $29,000. Annis Gardner Whiting Capital Advisors LLC lifted its stake in shares of Haleon by 402.0% in the 1st quarter. Annis Gardner Whiting Capital Advisors LLC now owns 3,002 shares of the company’s stock valued at $30,000 after purchasing an additional 2,404 shares during the last quarter. Stance Capital LLC bought a new stake in Haleon in the third quarter worth $34,000. Finally, Geneos Wealth Management Inc. boosted its holdings in Haleon by 33.0% in the first quarter. Geneos Wealth Management Inc. now owns 4,846 shares of the company’s stock worth $50,000 after purchasing an additional 1,203 shares in the last quarter. 6.67% of the stock is owned by institutional investors.

About Haleon

Haleon plc (NYSE:HLN) is a global consumer healthcare company formed through the separation of a large pharmaceutical group’s consumer health business in 2022. Headquartered in the United Kingdom, Haleon develops, manufactures and markets a broad portfolio of over‑the‑counter medicines, oral health products, vitamins, minerals and supplements, and other consumer health goods designed for daily self‑care and symptom relief.

The company’s product mix spans categories such as oral care (toothpastes and sensitivity treatments), pain relief and analgesics, respiratory remedies, digestive health products, topical treatments and nutritional supplements.